Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mirati Therapeutics (MRTX)

Mirati Therapeutics (MRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,001,036
  • Shares Outstanding, K 39,296
  • Annual Sales, $ 12,930 K
  • Annual Income, $ -98,420 K
  • 60-Month Beta 2.00
  • Price/Sales 264.70
  • Price/Cash Flow N/A
  • Price/Book 7.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -1.27
  • Number of Estimates 7
  • High Estimate -1.19
  • Low Estimate -1.40
  • Prior Year -0.85
  • Growth Rate Est. (year over year) -49.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
69.50 +8.17%
on 10/03/19
95.88 -21.59%
on 09/24/19
-18.26 (-19.54%)
since 09/20/19
3-Month
69.50 +8.17%
on 10/03/19
111.99 -32.87%
on 07/31/19
-30.82 (-29.08%)
since 07/19/19
52-Week
28.50 +163.79%
on 10/22/18
111.99 -32.87%
on 07/31/19
+35.17 (+87.90%)
since 10/19/18

Most Recent Stories

More News
Downtrend Call Working As Mirati Therapeut Stock Falls 4.6% (MRTX)

SmarTrend identified a Downtrend for Mirati Therapeut (NASDAQ:MRTX) on September 30th, 2019 at $80.63. In approximately 2 weeks, Mirati Therapeut has returned 4.58% as of today's recent price of $76.93....

MRTX : 74.81 (-2.04%)
Mirati Therapeutics To Present Pre-Clinical And Initial Clinical Data For MRTX849, A KRAS G12C Inhibitor, At The 2019 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced it will present pre-clinical data and initial clinical data on MRTX849, a novel and optimized KRAS...

MRTX : 74.81 (-2.04%)
Look for Shares of Mirati Therapeut to Potentially Pullback after Yesterday's 1.77% Rise

Mirati Therapeut (NASDAQ:MRTX) traded in a range yesterday that spanned from a low of $72.89 to a high of $74.86. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high...

MRTX : 74.81 (-2.04%)
Are Options Traders Betting on a Big Move in Mirati Therapeutics (MRTX) Stock?

Investors need to pay close attention to Mirati Therapeutics (MRTX) stock based on the movements in the options market lately.

MRTX : 74.81 (-2.04%)
Mirati Therapeut Falls 6.11% on Heavy Volume: Watch For Potential Rebound

Mirati Therapeut (NASDAQ:MRTX) traded in a range yesterday that spanned from a low of $78.46 to a high of $87.37. Yesterday, the shares fell 6.1%, which took the trading range below the 3-day low of...

MRTX : 74.81 (-2.04%)
Stemline Therape is Among the Companies in the Biotechnology Industry with the Best Relative Performance (STML , ADMS , MRTX, CHRS , RTRX )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

ADMS : 4.03 (+1.26%)
STML : 9.37 (+3.77%)
MRTX : 74.81 (-2.04%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (AIMT , ARWR, LJPC , MRTX, AGIO )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

AIMT : 25.70 (+2.19%)
LJPC : 8.78 (+3.91%)
ARWR : 36.14 (+0.53%)
MRTX : 74.81 (-2.04%)
Mirati Therapeut Has Returned 15.1% Since SmarTrend Recommendation (MRTX)

SmarTrend identified a Downtrend for Mirati Therapeut (NASDAQ:MRTX) on July 26th, 2019 at $97.26. In approximately 2 months, Mirati Therapeut has returned 15.14% as of today's recent price of $82.53.

MRTX : 74.81 (-2.04%)
Mirati Therapeut Rises 4.62% on Heavy Volume: Watch For Potential Pullback

Mirati Therapeut (NASDAQ:MRTX) traded in a range yesterday that spanned from a low of $86.00 to a high of $93.89. Yesterday, the shares gained 4.6%, which took the trading range above the 3-day high...

MRTX : 74.81 (-2.04%)
Amgen's KRAS Inhibitor Shows Response in Larger NSCLC Group

Amgen's (AMGN) novel investigational KRAS inhibitor, AMG 510, for solid tumor shows anti-tumor activity in a larger group of NSCLC patients.

ALXN : 100.83 (+2.46%)
AMGN : 201.96 (-0.37%)
BIIB : 224.85 (+2.18%)
MRTX : 74.81 (-2.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade MRTX with:

Business Summary

Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.

See More

Key Turning Points

2nd Resistance Point 91.12
1st Resistance Point 83.75
Last Price 74.81
1st Support Level 72.25
2nd Support Level 68.12

See More

52-Week High 111.99
Fibonacci 61.8% 80.10
Last Price 74.81
Fibonacci 50% 70.24
Fibonacci 38.2% 60.39
52-Week Low 28.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar